Search Weight Loss Topics:




Feb 24

Testosterone replacement therapy market: North America to account … – Yahoo Finance

Testosterone Comments Off on Testosterone replacement therapy market: North America to account … – Yahoo Finance

NEW YORK, Feb. 17, 2023 /PRNewswire/ --The testosterone replacement therapy market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 3.1% and register an incremental growth of USD 402.87 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF sample report

Technavio has announced its latest market research report titled Global Testosterone Replacement Therapy Market 2022-2026

Company profiles

The testosterone replacement therapy market report includes information on the key products and recent developments of leading vendors, including:

AbbVie Inc.:The company offers testosterone replacement therapy using Androgel, which is used to treat adult males with low or no testosterone due to certain medical conditions.

Acerus Pharmaceuticals Corp.:The company offers testosterone replacement therapy using Natesto.

Antares Pharma Inc.:The company offers testosterone replacement therapy using Tilando, an oral treatment.

Bayer AG:The company offers testosterone replacement therapy using tools that allow for easy testosterone conversion and free testosterone calculation and provide an algorithm for diagnosis and treatment of hypogonadism.

Clarus Therapeutics Inc.:The company offers testosterone replacement therapy using Jatezno capsules, which are used for adult males in conditions associated with a deficiency or absence of endogenous testosterone.

Eli Lilly and Co.

Endo International Plc

Novartis AG

Pfizer Inc.

To gain access to more vendor profiles available with Technavio, buy the report!

Regional analysis

Based on region, the global testosterone replacement therapy market is segmented into North America, Europe, Asia, and the Rest of the World (ROW). North America is estimated to account for 58% of the growth of the global market over the forecast period. The increasing cases of hypogonadism and the rising awareness about the treatment of testosterone deficiency and erectile dysfunction are driving the growth of the regional market.

Story continues

Market dynamics

The market is driven by factors such as initiatives to increase awareness about hypogonadism among the population, the rising incidence of chronic diseases, and untapped potential in developing countries. However, the availability of generics is hindering the market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, among others. Request a sample

Market Segmentation

Based on product, the market is segmented into injectables, topicals, and others.

Based on geography, the market is segmented into North America, Europe, Asia, and the Rest of the World (ROW).

Related Reports:

The total wrist replacement market size is expected to increase by USD 165.9 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 3.9%. The growing number of road accidents and fatal sports injuries is notably driving the total wrist replacement market growth, although factors such as the lack of skilled surgeons may impede the market growth.

The knee replacement market size is expected to increase by USD 2.58 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.92%. The technological advances and new product launches are notably driving the knee replacement market growth, although factors such as high implant prices coupled with decreasing reimbursement may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this testosterone replacement therapy market report?

CAGR of the market during the forecast period2022-2026.

Detailed information on factors that will drivetestosterone replacement therapy market growth during the next five years.

Precise estimation of the testosterone replacement therapy marketsize and its contribution to the parent market.

Accurate predictions on upcoming trends and changes in consumer behavior.

The growth of the testosterone replacement therapy industry across North America, Europe, Asia, and the Rest of the World (ROW).

A thorough analysis of the market's competitive landscape and detailed information on vendors.

Comprehensive details of factors that will challenge the growth of testosterone replacement therapy marketvendors.

Testosterone Replacement Therapy Market Scope

Report Coverage

Details

Page number

135

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 3.1%

Market growth 2022-2026

USD 402.87 million

Market structure

Fragmented

YoY growth 2021-2022 (%)

2.5

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 58%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Key companies profiled

AbbVie Inc., Acerus Pharmaceuticals Corp., Acrux Ltd., Actiza Pharmaceutical Pvt. Ltd., Antares Pharma Inc., Aytu BioPharma Inc., Bausch Health Co. Inc., Bayer AG, BIOTE MEDICAL LLC, Cipla Ltd., Clarus Therapeutics Inc., Eli Lilly, and Co., Endo International Plc, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., The Simple Pharma Co. UK Ltd., Upsher Smith Laboratories LLC, and Viatris Inc.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio health care marketreports

Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.comWebsite: http://www.technavio.com/

Global Testosterone Replacement Therapy Market 2022-2026

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/testosterone-replacement-therapy-market-north-america-to-account-for-58-of-market-growth-driven-by-initiatives-to-increase-awareness-about-hypogonadism-among-the-population---technavio-301748535.html

SOURCE Technavio

Link:
Testosterone replacement therapy market: North America to account ... - Yahoo Finance

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker